NO20043295L - Faste salt-benzazepinforbindelser og deres anvendelse ved fremstilling av farmasoytiske forbindelser - Google Patents

Faste salt-benzazepinforbindelser og deres anvendelse ved fremstilling av farmasoytiske forbindelser

Info

Publication number
NO20043295L
NO20043295L NO20043295A NO20043295A NO20043295L NO 20043295 L NO20043295 L NO 20043295L NO 20043295 A NO20043295 A NO 20043295A NO 20043295 A NO20043295 A NO 20043295A NO 20043295 L NO20043295 L NO 20043295L
Authority
NO
Norway
Prior art keywords
compounds
preparation
solid salt
benzazepine
pharmaceutical
Prior art date
Application number
NO20043295A
Other languages
English (en)
Other versions
NO330528B1 (no
Inventor
Paulus Franciscus Corneli Meij
Joris A Van Der Eerden
Paulus Pg De Jong
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of NO20043295L publication Critical patent/NO20043295L/no
Publication of NO330528B1 publication Critical patent/NO330528B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20043295A 2002-01-16 2004-08-06 Nye salter av benzazepinforbindelser, fremgangsmater for fremstilling derav, og anvendelse av slike i farmasoytiske sammensetninger NO330528B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02075621 2002-01-16
NL1019762 2002-01-17
PCT/EP2003/000515 WO2003059939A1 (en) 2002-01-16 2003-01-15 Solid salts benzazepine compounds and their use in the preparation of pharmaceuticals compounds

Publications (2)

Publication Number Publication Date
NO20043295L true NO20043295L (no) 2004-08-06
NO330528B1 NO330528B1 (no) 2011-05-09

Family

ID=26077601

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20043295A NO330528B1 (no) 2002-01-16 2004-08-06 Nye salter av benzazepinforbindelser, fremgangsmater for fremstilling derav, og anvendelse av slike i farmasoytiske sammensetninger

Country Status (16)

Country Link
US (1) US6998398B2 (no)
EP (1) EP1468010A1 (no)
JP (1) JP4384495B2 (no)
KR (1) KR100979077B1 (no)
CN (1) CN100591689C (no)
AU (1) AU2003206755B2 (no)
BR (1) BR0306701A (no)
CA (1) CA2473447A1 (no)
HK (1) HK1072946A1 (no)
HR (1) HRP20040560A2 (no)
IL (1) IL162645A0 (no)
MX (1) MXPA04006887A (no)
NO (1) NO330528B1 (no)
PL (1) PL371511A1 (no)
RU (1) RU2303041C2 (no)
WO (1) WO2003059939A1 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050009031A (ko) * 2003-07-15 2005-01-24 엘지전자 주식회사 1회 기록 가능한 광디스크 및 광디스크의 관리정보 기록방법
SA04250283B1 (ar) * 2003-09-26 2008-05-26 سولفاي فارماسيتيكالز جي أم بي أتش مشتقات من amidomethy1-substituted1-(carboxyalkyl)-cyclopentylcarbonylamino-benzazepine-N-acetic acid
JP4824573B2 (ja) 2003-11-18 2011-11-30 ゾルファイ ファーマスーティカルズ ゲゼルシャフト ミット ベシュレンクテル ハフツング 腎不全、腎疾患または腎障害、特に糖尿病患者におけるこれらの治療のための医薬組成物
US20050267124A1 (en) * 2004-05-14 2005-12-01 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous producing system and PDEV inhibiitors
EP1827448A1 (en) 2004-12-15 2007-09-05 Solvay Pharmaceuticals GmbH Pharmaceutical compositions comprising nep-inhibitors, inhibitors of the endogenous endothelin producing system and hmg coa reductase inhibitors
US20060159748A1 (en) * 2004-12-23 2006-07-20 Rajesh Jain Oral immediate release formulation of a poorly water-soluble active substance
US20060205625A1 (en) * 2005-02-18 2006-09-14 Solvay Pharmaceuticals Gmbh Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and diuretics
WO2007054975A1 (en) * 2005-11-08 2007-05-18 Panacea Biotec Ltd Pharmaceutical compositions for the treatment of cardiovascular and other associated disorders
HU227696B1 (en) * 2006-04-13 2011-12-28 Egyt Gyogyszervegyeszeti Gyar Zinc salt of rosuvastatin, process for its preparation and pharmaceutical compositions containing it
PL424452A1 (pl) 2018-01-31 2019-08-12 Forty-Four Pharmaceuticals Spółka Z Ograniczoną Odpowiedzialnością Inhibitory obojętnej endopeptydazy (NEP) i ludzkiej rozpuszczalnej endopeptydazy (hSEP) do profilaktyki i leczenia chorób oczu

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19510566A1 (de) * 1995-03-23 1996-09-26 Kali Chemie Pharma Gmbh Benzazepin-, Benzoxazepin- und Benzothiazepin-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19638020A1 (de) * 1996-09-18 1998-03-19 Solvay Pharm Gmbh Die gastrointestinale Durchblutung fördernde Arzneimittel
DE19750002A1 (de) * 1997-11-12 1999-05-20 Solvay Pharm Gmbh Phosphonsäure-substituierte Benzazepinon-N-essigsäurederivate sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE19906310A1 (de) * 1999-02-16 2000-08-17 Solvay Pharm Gmbh Arzneimittel zur Behandlung von Bluthochdruck
DE19932555A1 (de) * 1999-07-13 2001-01-18 Solvay Pharm Gmbh Arzneimittel mit protektiver Wirkung gegen oxidativ-toxische und insbesondere gegen kardiotoxische Substanzen

Also Published As

Publication number Publication date
WO2003059939A1 (en) 2003-07-24
IL162645A0 (en) 2005-11-20
PL371511A1 (en) 2005-06-27
CN1617883A (zh) 2005-05-18
CN100591689C (zh) 2010-02-24
HK1072946A1 (en) 2005-09-16
HRP20040560A2 (en) 2004-10-31
KR100979077B1 (ko) 2010-08-31
NO330528B1 (no) 2011-05-09
AU2003206755B2 (en) 2008-07-17
RU2303041C2 (ru) 2007-07-20
JP2005520809A (ja) 2005-07-14
EP1468010A1 (en) 2004-10-20
AU2003206755A1 (en) 2003-07-30
US6998398B2 (en) 2006-02-14
CA2473447A1 (en) 2003-07-24
KR20040089106A (ko) 2004-10-20
BR0306701A (pt) 2004-12-28
RU2004124840A (ru) 2006-01-20
JP4384495B2 (ja) 2009-12-16
US20050038012A1 (en) 2005-02-17
MXPA04006887A (es) 2004-12-06

Similar Documents

Publication Publication Date Title
AU2003224638A8 (en) Pdpk1s as modifiers of the p53 pathway and methods of use
EP1402058A4 (en) DGKS AS P53 PATH MODIFICATORS AND METHOD OF USE
NO20053920D0 (no) Preparat for og behandling av demyelineringssykdommer og paralyse ved administrering av remyelineringsmidler.
HK1091199A1 (en) Quinazoline derivatives and use thereof in the manufacture of medicaments
NO20055652D0 (no) Laktatinneholdende farmasoytisk preparat og anvendelse av dette
IL176248A0 (en) N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
PL377931A1 (pl) Farmaceutyczne preparaty donosowe oraz sposoby ich stosowania
EE05507B1 (et) Rosuvastatiini ZD4522) kasutamine heterosgootseperekondliku hperkolesteroleemia raviks
HK1091727A1 (en) Nasal pharmaceutical formulations and methods of using the same
NO20025357D0 (no) Antranylamider og deres anvendelse som legemidler
EP1466175A4 (en) SPHICAS AS P53 PATH MODIFICATORS AND USE METHOD
EE05020B1 (et) Glburiidi ravimkoostis
NO20054535D0 (no) Bifunksjonelle heterocykliske forbindelser og fremgangsmater for fremstilling og anvendelse av samme
IS6966A (is) Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
HK1072946A1 (en) Solid salts benzazepine compounds and their use in the preparation of pharmaceuticals compounds
NO20041214L (no) Substituerte benzimidazolforbindelser og deres anvendelse for behandling av cancer
FI20002114A (fi) Rekombinanttientsyymien käyttö GDP-L-fukoosin ja fukosyloitujen glykaanien valmistamiseksi
AU2002314887A1 (en) Gads as modifiers of the p53 pathway and methods of use
NO20022022L (no) N-guanidinoalkylamider, deres fremstilling, deres anvendelse og farmasöytiske preparater omfattende disse
DE60232445D1 (de) Cetirizin und pseudoephedrin enthaltende tablette
DK1353912T3 (da) 2-Arylimino-2,3-dihydrothiazolderivater, fremgangsmåderne til deres fremstilling og deres terapeutiske anvendelse
DK1212336T3 (da) Fremgangsmåde til fremstilling af sfæriske agglomerater af telithromycin og deres anvendelse ved fremstilling af farmaceutiske former
EE200300466A (et) Püridoindolooni derivaatide kasutamine ravimite valmistamiseks
DK1680405T3 (da) Bengamidderivater og deres anvendelse til behandling af kræftsygdomme

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees